Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Karlsson, Elin ^a   Delle, Ulla ^a   Danielsson, Anna ^a   Olsson, Björn ^b   Abel, Frida ^c   Karlsson, Per ^d   Helou, Khalil ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF SKÖVDE   (Sweden)

^c Genomics Core Facility   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; AMINOTRANSFERASE; MEMBRANE PROTEIN; MESSENGER RNA; MYOSIN; NUCLEOPHOSMIN; PROTHROMBIN; TRANSCRIPTION FACTOR E2F; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSLATION TERMINATION FACTOR; ZINC FINGER PROTEIN; TUMOR MARKER;

ACCURACY; ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MASTECTOMY; NUCLEOTIDE SEQUENCE; PREDICTION; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; BREAST TUMOR; CLUSTER ANALYSIS; FEMALE; FOLLOW UP; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PAGET NIPPLE DISEASE; PATHOLOGY; PREDICTION AND FORECASTING;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CLUSTER ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 53549094961     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-254     Document Type: Article

References (48)

1. Jemal A Siegel R Ward E Murray T Xu J Smigal C Thun MJ Cancer statistics, 2006 CA Cancer J Clin 2006, 56(2):106-130 16514137
2. Michaelson JS Silverstein M Sgroi D Cheongsiatmoy JA Taghian A Powell S Hughes K Comegno A Tanabe KK Smith B The effect of tumor size and lymph node status on breast carcinoma lethality Cancer 2003, 98(10):2133-2143 10.1002/cncr.11765 14601082
3. van't Veer LJ Dai H Vijver van de MJ He YD Hart AA Mao M Peterse HL Kooy van der K Marton MJ Witteveen AT Gene expression profiling predicts clinical outcome of breast cancer Nature 2002, 415(6871):530-536 10.1038/ 415530a 11823860
4. Wang Y Klijn JG Zhang Y Sieuwerts AM Look MP Yang F Talantov D Timmermans M Meijer-van Gelder ME Yu J Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 2005, 365(9460):671-679 15721472
5. Swegene DNA Microarray Resource Centre http://swegene.onk.lu.se
6. Schroeder A Mueller O Stocker S Salowsky R Leiber M Gassmann M Lightfoot S Menzel W Granzow M Ragg T The RIN: An RNA integrity number for assigning integrity values to RNA measurements BMC Mol Biol 2006, 7:3 1413964 16448564 10.1186/1471-2199-7-3
7. Barrett T Troup DB Wilhite SE Ledoux P Rudnev D Evangelista C Kim IF Soboleva A Tomashevsky M Edgar R NCBI GEO: Mining tens of millions of expression profiles-database and tools update Nucleic Acids Res 2007, 35 Database D760-765 1669752 17099226 10.1093/nar/gkl887
8. Gene Expression Omnibus http://www.ncbi.nlm.nih.gov/geo/
9. Saal LH Troein C Vallon-Christersson J Gruvberger S Borg A Peterson C BioArray Software Environment (BASE): A platform for comprehensive management and analysis of microarray data Genome Biol 2002, 3(8):SOFTWARE0003 139402 12186655 10.1186/gb-2002-3-8-software0003
10. Internal BASE at Lund University http://base.onk.lu.se
11. Entrez Gene http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene
12. Caraux G Pinloche S PermutMatrix: A graphical environment to arrange gene expression profiles in optimal linear order Bioinformatics 2005, 21(7):1280-1281 10.1093/bioinformatics/bti141 15546938
13. Frank E Hall M Trigg L Holmes G Witten IH Data mining in bioinformatics using Weka Bioinformatics 2004, 20(15):2479-2481 10.1093/bioinformatics/ bth261 15073010
14. Demiroz G Guvenir HA Classification by voting feature intervals Lect Notes Artif Int 1997, 1224:85-92
15. Applied Biosystems https://products.appliedbiosystems.com
16. Karlsson E Danielsson A Delle U Olsson B Karlsson P Helou K Chromosomal changes associated with clinical outcome in lymph node-negative breast cancer Cancer Genet Cytogenet 2007, 172(2):139-146 10.1016/ j.cancergencyto.2006.09.019 17213022
17. Cheng SH Horng CF West M Huang E Pittman J Tsou MH Dressman H Chen CM Tsai SY Jian JJ Genomic prediction of locoregional recurrence after mastectomy in breast cancer J Clin Oncol 2006, 24(28):4594-4602 10.1200/ JCO.2005.02.5676 17008701
18. Dahl E Kristiansen G Gottlob K Klaman I Ebner E Hinzmann B Hermann K Pilarsky C Durst M Klinkhammer-Schalke M Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer Clin Cancer Res 2006, 12(13):3950-3960 10.1158/ 1078-0432.CCR-05-2090 16818692
19. Feng Y Sun B Li X Zhang L Niu Y Xiao C Ning L Fang Z Wang Y Cheng J Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients Breast Cancer Res Treat 2006 17123152
20. Gruvberger-Saal SK Eden P Ringner M Baldetorp B Chebil G Borg A Ferno M Peterson C Meltzer PS Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles Mol Cancer Ther 2004, 3(2):161-168 14985456
21. Huang E Cheng SH Dressman H Pittman J Tsou MH Horng CF Bild A Iversen ES Liao M Chen CM Gene expression predictors of breast cancer outcomes Lancet 2003, 361(9369):1590-1596 10.1016/S0140-6736(03)13308-9 12747878
22. Jenssen TK Kuo WP Stokke T Hovig E Associations between gene expressions in breast cancer and patient survival Hum Genet 2002, 111(4-5):411-420 12384785
23. Jones C Mackay A Grigoriadis A Cossu A Reis-Filho JS Fulford L Dexter T Davies S Bulmer K Ford E Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer Cancer Res 2004, 64(9):3037-3045 10.1158/0008-5472.CAN-03-2028 15126339
24. Korkola JE Blaveri E DeVries S Moore DH 2nd Hwang ES Chen YY Estep AL Chew KL Jensen RH Waldman FM Identification of a robust gene signature that predicts breast cancer outcome in independent data sets BMC Cancer 2007, 7:61 1855059 17428335 10.1186/1471-2407-7-61
25. Li LF Xu XJ Zhao Y Liu ZB Shen ZZ Jin WR Shao ZM Integrated gene expression profile predicts prognosis of breast cancer patients Breast Cancer Res Treat 2008
26. Miller LD Smeds J George J Vega VB Vergara L Ploner A Pawitan Y Hall P Klaar S Liu ET An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Proc Natl Acad Sci USA 2005, 102(38):13550-13555 1197273 16141321 10.1073/pnas.0506230102
27. Naderi A Teschendorff AE Barbosa-Morais NL Pinder SE Green AR Powe DG Robertson JF Aparicio S Ellis IO Brenton JD A gene-expression signature to predict survival in breast cancer across independent data sets Oncogene 2006, 26(10):1507-1516 10.1038/sj.onc.1209920 16936776
28. Nuyten DS Kreike B Hart AA Chi JT Sneddon JB Wessels LF Peterse HJ Bartelink H Brown PO Chang HY Predicting a local recurrence after breast-conserving therapy by gene expression profiling Breast Cancer Res 2006, 8(5):R62 1779489 17069664 10.1186/bcr1614
29. Onda M Emi M Nagai H Nagahata T Tsumagari K Fujimoto T Akiyama F Sakamoto G Makita M Kasumi F Gene expression patterns as marker for 5-year postoperative prognosis of primary breast cancers J Cancer Res Clin Oncol 2004, 130(9):537-545 10.1007/s00432-004-0574-7 15235906
30. Perou CM Sorlie T Eisen MB Rijn van de M Jeffrey SS Rees CA Pollack JR Ross DT Johnsen H Akslen LA Molecular portraits of human breast tumours Nature 2000, 406(6797):747-752 10.1038/35021093 10963602
31. Sorlie T Perou CM Tibshirani R Aas T Geisler S Johnsen H Hastie T Eisen MB Rijn van de M Jeffrey SS Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 2001, 98(19):10869-10874 58566 11553815 10.1073/ pnas.191367098
32. Tsumagari K Chijiiwa K Nagai H Makita M Kasumi F Akiyama F Sakamoto G Miki Y Postoperative prognosis of node-negative breast cancers predicted by gene-expression profiling on a cDNA microarray of 25,344 genes Breast Cancer 2005, 12(3):166-177 10.2325/jbcs.12.166 16110286
33. Vijver van de MJ He YD van't Veer LJ Dai H Hart AA Voskuil DW Schreiber GJ Peterse JL Roberts C Marton MJ A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 2002, 347(25):1999-2009 10.1056/NEJMoa021967 12490681
34. Glas AM Floore A Delahaye LJ Witteveen AT Pover RC Bakx N Lahti-Domenici JS Bruinsma TJ Warmoes MO Bernards R Converting a breast cancer microarray signature into a high-throughput diagnostic test BMC Genomics 2006, 7:278 1636049 17074082 10.1186/1471-2164-7-278
35. Ein-Dor L Kela I Getz G Givol D Domany E Outcome signature genes in breast cancer: Is there a unique set? Bioinformatics 2005, 21(2):171-178 10.1093/bioinformatics/bth469 15308542
36. Flanagan JM Gerber AL Cadet JL Beutler E Sipe JC The fatty acid amide hydrolase 385 A/A (P129T) variant: Haplotype analysis of an ancient missense mutation and validation of risk for drug addiction Hum Genet 2006, 120(4):581-588 10.1007/s00439-006-0250-x 16972078
37. Yoshikawa R Yanagi H Shen CS Fujiwara Y Noda M Yagyu T Gega M Oshima T Yamamura T Okamura H ECA39 is a novel distant metastasis-related biomarker in colorectal cancer World J Gastroenterol 2006, 12(36):5884-5889 17007058
38. He P Varticovski L Bowman ED Fukuoka J Welsh JA Miura K Jen J Gabrielson E Brambilla E Travis WD Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray Hum Pathol 2004, 35(10):1196-1209 10.1016/ j.humpath.2004.06.014 15492986
39. ten Berge RL Meijer CJ Dukers DF Kummer JA Bladergroen BA Vos W Hack CE Ossenkoppele GJ Oudejans JJ Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma Blood 2002, 99(12):4540-4546 10.1182/blood.V99.12.4540 12036886
40. van Houdt IS Oudejans JJ Eertwegh van den AJ Baars A Vos W Bladergroen BA Rimoldi D Muris JJ Hooijberg E Gundy CM Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma Clin Cancer Res 2005, 11(17):6400-6407 10.1158/1078-0432.CCR-05-0306 16144945
41. Ma Y Cui W Yang J Qu J Di C Amin HM Lai R Ritz J Krause DS Chai L SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice Blood 2006, 108(8):2726-2735 1895586 16763212 10.1182/blood-2006-02-001594
42. Muller-Pillasch F Wallrapp C Lacher U Friess H Buchler M Adler G Gress TM Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer Gene 1998, 208(1):25-30 10.1016/ S0378-1119(97)00633-1 9479038
43. Bandaru V Sunkara S Wallace SS Bond JP A novel human DNA glycosylase that removes oxidative DNA damage and is homologous to Escherichia coli endonuclease VIII DNA Repair (Amst) 2002, 1(7):517-529 10.1016/ S1568-7864(02)00036-8 12509226
44. Shinmura K Tao H Goto M Igarashi H Taniguchi T Maekawa M Takezaki T Sugimura H Inactivating mutations of the human base excision repair gene NEIL1 in gastric cancer Carcinogenesis 2004, 25(12):2311-2317 10.1093/ carcin/bgh267 15319300
45. Frank SR Adelstein MR Hansen SH GIT2 represses Crk- and Rac1-regulated cell spreading and Cdc42-mediated focal adhesion turnover Embo J 2006, 25(9):1848-1859 1456948 16628223 10.1038/sj.emboj.7601092
46. Toby GG Gherraby W Coleman TR Golemis EA A novel RING finger protein, human enhancer of invasion 10, alters mitotic progression through regulation of cyclin B levels Mol Cell Biol 2003, 23(6):2109-2122 149478 12612082 10.1128/MCB.23.6.2109-2122.2003
47. Andrews P He YJ Xiong Y Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function Oncogene 2006, 25(33):4534-4548 10.1038/sj.onc.1209490 16547496
48. Leone G Sears R Huang E Rempel R Nuckolls F Park CH Giangrande P Wu L Saavedra HI Field SJ Myc requires distinct E2F activities to induce S phase and apoptosis Mol Cell 2001, 8(1):105-113 10.1016/ S1097-2765(01)00275-1 11511364